Seguir
Loreto Carmona
Loreto Carmona
Instituto de Salud Musculoesquelética
Dirección de correo verificada de inmusc.eu - Página principal
Título
Citado por
Citado por
Año
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ...
The lancet 380 (9859), 2197-2223, 2012
100932012
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ...
The lancet 380 (9859), 2163-2196, 2012
89022012
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active‐surveillance report
JJ Gómez‐Reino, L Carmona, VR Valverde, EM Mola, MD Montero
Arthritis & Rheumatism: Official Journal of the American College of …, 2003
12832003
The burden of musculoskeletal diseases in the general population of Spain: results from a national survey
L Carmona, J Ballina, R Gabriel, A Laffon
Annals of the rheumatic diseases 60 (11), 1040-1045, 2001
10642001
The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study
M Cross, E Smith, D Hoy, L Carmona, F Wolfe, T Vos, B Williams, ...
Annals of the rheumatic diseases 73 (7), 1316-1322, 2014
10192014
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ...
Annals of the rheumatic diseases 79 (7), 859-866, 2020
9372020
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona, JJ Gómez‐Reino, V Rodríguez‐Valverde, D Montero, ...
Arthritis & Rheumatism 52 (6), 1766-1772, 2005
7802005
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research …
K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ...
Annals of the Rheumatic Diseases 68 (7), 1086-1093, 2009
6132009
Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography
E Naredo, G Bonilla, F Gamero, J Uson, L Carmona, A Laffon
Annals of the rheumatic diseases 64 (3), 375-381, 2005
5692005
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ...
European Respiratory Journal 36 (5), 1185-1206, 2010
5482010
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
JJ Gómez‐Reino, L Carmona, M Ángel Descalzo
Arthritis Care & Research: Official Journal of the American College of …, 2007
4972007
Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression
E Naredo, P Collado, A Cruz, MJ Palop, F Cabero, P Richi, L Carmona, ...
Arthritis Care & Research: Official Journal of the American College of …, 2007
4622007
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
M Mosca, C Tani, M Aringer, S Bombardieri, D Boumpas, R Brey, ...
Annals of the rheumatic diseases 69 (7), 1269-1274, 2010
4552010
The prevalence of rheumatoid arthritis in the general population of Spain
L Carmona, V Villaverde, C Hernández‐García, J Ballina, R Gabriel, ...
Rheumatology 41 (1), 88-95, 2002
4352002
EULAR recommendations for the management of familial Mediterranean fever
S Ozen, E Demirkaya, B Erer, A Livneh, E Ben-Chetrit, G Giancane, ...
Annals of the rheumatic diseases 75 (4), 644-651, 2016
4222016
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ...
Annals of the rheumatic diseases 80 (7), 930-942, 2021
4172021
Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain
AJ Mas, L Carmona, M Valverde, B Ribas
Clinical & Experimental Rheumatology 26 (4), 519, 2008
3812008
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
JJ Gomez-Reino, L Carmona
Arthritis research & therapy 8 (1), 1-7, 2006
3772006
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of …
F Sivera, M Andrés, L Carmona, ASR Kydd, J Moi, R Seth, ...
Annals of the rheumatic diseases 73 (2), 328-335, 2014
3752014
Power Doppler ultrasonographic monitoring of response to anti–tumor necrosis factor therapy in patients with rheumatoid arthritis
E Naredo, I Möller, A Cruz, L Carmona, J Garrido
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
3382008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20